Published in Br J Ind Med on November 01, 1991
Protective effects of thymoquinone on the neuronal injury in frontal cortex after chronic toluene exposure. J Mol Histol (2010) 0.89
Correlation between Patent Foramen Ovale, Cerebral "Lesions" and Neuropsychometric Testing in Experienced Sports Divers: Does Diving Damage the Brain? Front Psychol (2016) 0.88
Neurotoxicity following acute inhalation of aerosols generated during resistance spot weld-bonding of carbon steel. Inhal Toxicol (2014) 0.79
Exposure to organic solvents. A cross-sectional epidemiologic investigation on occupationally exposed care and industrial spray painters with special reference to the nervous system. Scand J Work Environ Health (1980) 2.67
A computer-administered neurobehavioral evaluation system for occupational and environmental epidemiology. Rationale, methodology, and pilot study results. J Occup Med (1985) 2.35
Long-term exposure to jet fuel. II. A cross-sectional epidemiologic investigation on occupationally exposed industrial workers with special reference to the nervous system. Scand J Work Environ Health (1978) 1.58
A computer-based neurobehavioral evaluation system for occupational and environmental epidemiology: methodology and validation studies. Neurobehav Toxicol Teratol (1985) 1.21
Use of behavioral performance tests in the assessment of solvent toxicity. Scand J Work Environ Health (1985) 1.18
Effects on psychological test performance of workers exposed to a single solvent (toluene)--a comparison with effects of exposure to a mixture of organic solvents. Neurobehav Toxicol Teratol (1983) 1.18
Effects of acute exposure of toluene and methyl ethyl ketone on psychomotor performance. Int Arch Occup Environ Health (1984) 1.13
Effect of occupational exposure to elemental mercury on short term memory. Br J Ind Med (1983) 1.13
Behavioural evaluation of workers exposed to mixtures of organic solvents. Br J Ind Med (1985) 1.04
Neurobehavioral testing of chemicals: impact on recommended standards. Neurobehav Toxicol Teratol (1984) 0.98
Acute neurobehavioural effects of toluene. Br J Ind Med (1989) 0.90
Experimental exposure to toluene in combination with ethanol intake. Psychophysiological functions. Scand J Work Environ Health (1986) 0.89
Human response to controlled levels of toluene in six-hour exposures. Scand J Work Environ Health (1983) 0.89
Variability of the blood:breath alcohol ratio in vivo. J Stud Alcohol (1978) 0.86
Effects of alcohol and extended practice on divided-attention performance. Percept Psychophys (1990) 0.83
Combined effects of propranolol and ethanol on human psychomotor performance. Toxicol Appl Pharmacol (1983) 0.83
Sample sizes in the multivariate analysis of repeated measurements. Biometrics (1986) 0.82
Trichloroethylene in combination with CNS drugs. Effects on visual-motor tests. Arch Environ Health (1970) 0.81
The effects of toluene and alcohol on psychomotor performance. Ergonomics (1983) 0.80
Ethyl alcohol: blood levels and performance decrements after oral administration to man. Psychopharmacologia (1971) 0.80
Effects of ethanol: II. Behavioral sensitivity and acute behavioral tolerance. Alcohol Clin Exp Res (1984) 0.78
Effects of alcohol on a Critical Tracking Task. J Stud Alcohol (1975) 0.78
[The effects of small amounts of alcohol on in-flight activity]. Minerva Med (1981) 0.78
Validation of human behavioral tests using ethanol as a CNS depressant model. Neurobehav Toxicol Teratol (1985) 0.78
Acute behavioral effects of exposure to some organic solvents -psychophysiological aspects. Acta Neurol Scand Suppl (1982) 0.78
Computerized assessment of human neurotoxicity: sensitivity to nitrous oxide exposure. Clin Pharmacol Ther (1985) 0.78
Behavioral effects of 0 and 0.05% blood alcohol in male volunteers. Neurobehav Toxicol Teratol (1986) 0.77
EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol (2006) 2.86
Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology (2005) 2.69
Mechanism of active chloride secretion by shark rectal gland: role of Na-K-ATPase in chloride transport. Am J Physiol (1977) 2.08
Anticholinergics for symptomatic management of Parkinson's disease. Cochrane Database Syst Rev (2003) 1.91
Report of the task force on designing clinical trials in early (predementia) AD. Neurology (2010) 1.75
Job task and psychosocial risk factors for work-related musculoskeletal disorders among newspaper employees. Scand J Work Environ Health (1994) 1.63
The hollow denture: an alternative treatment for atrophic maxillae. J Prosthet Dent (1988) 1.55
The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor. J Med Genet (2005) 1.40
The biology of renal hypertrophy. Kidney Int (1986) 1.30
Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. Eur J Neurol (2013) 1.24
Botulinum toxin type A therapy for cervical dystonia. Cochrane Database Syst Rev (2005) 1.18
The prevalence of back pain, hand discomfort, and dermatitis in the US working population. Am J Public Health (1994) 1.18
Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data. Neurology (2008) 1.14
Research findings linking workplace factors to CVD outcomes. Occup Med (2000) 1.11
Effect of ropinirole on sleep onset: a randomized, placebo-controlled study in healthy volunteers. Neurology (2002) 1.07
Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: a systematic review. Parkinsonism Relat Disord (2009) 1.06
The European Multiple System Atrophy-Study Group (EMSA-SG). J Neural Transm (Vienna) (2005) 1.05
The NIOSH review of hand-arm vibration syndrome: vigilance is crucial. National Institute of Occupational Safety and Health. J Occup Environ Med (1998) 1.04
Hand-wrist disorders among investment casting plant workers. J Hand Surg Am (1987) 1.03
Shift work, shift change, and risk of death from heart disease at work. Am J Ind Med (1996) 1.02
Alzheimer's disease therapeutic trials: EU/US Task Force report on recruitment, retention, and methodology. J Nutr Health Aging (2012) 1.00
Optic disk edema associated with peripapillary serous retinal detachment: an early sign of systemic Bartonella henselae infection. Am J Ophthalmol (2000) 0.98
On the biology of sodium excretion: The search for a natriuretic hormone. Yale J Biol Med (1975) 0.95
Botulinum toxin type B for cervical dystonia. Cochrane Database Syst Rev (2005) 0.95
Brachial plexopathy after Botulinum toxin administration for cervical dystonia. J Neurol Neurosurg Psychiatry (1993) 0.94
A behavioral evaluation of PCE exposure in patients and dry cleaners: a possible relationship between clinical and preclinical effects. J Occup Environ Med (1995) 0.92
Skin antiseptics in venous puncture-site disinfection for prevention of blood culture contamination: systematic review with meta-analysis. J Hosp Infect (2010) 0.92
Guidelines for medical screening in the workplace. Occup Med (1990) 0.92
Carla Task Force on Sarcopenia: propositions for clinical trials. J Nutr Health Aging (2009) 0.90
Nasal videoendoscopy in prosthetic management of palatopharyngeal dysfunction. J Prosthet Dent (1987) 0.90
Acute neurobehavioural effects of toluene. Br J Ind Med (1989) 0.90
Botulinum toxin type A therapy for hemifacial spasm. Cochrane Database Syst Rev (2005) 0.90
Antibiotic prophylaxis for preventing meningitis in patients with basilar skull fractures. Cochrane Database Syst Rev (2006) 0.86
What is the role of chemotherapy in estrogen receptor-positive, advanced breast cancer? Ann Oncol (2009) 0.86
Perchloroethylene exposure assessment among dry cleaning workers. Am Ind Hyg Assoc J (1990) 0.85
Genetic polymorphism of the alpha 2-adrenergic receptor is associated with increased platelet aggregation, baroreceptor sensitivity, and salt excretion in normotensive humans. Am J Hypertens (1995) 0.85
Human plasma kallikrein. Purification and preliminary characterization. Arch Biochem Biophys (1974) 0.85
Botulinum toxin type A therapy for blepharospasm. Cochrane Database Syst Rev (2005) 0.85
Botulinum toxin type A versus botulinum toxin type B for cervical dystonia. Cochrane Database Syst Rev (2005) 0.84
Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts. Cochrane Database Syst Rev (2006) 0.84
New method for coloring facial prostheses. J Prosthet Dent (1978) 0.84
A retrospective study of osseointegrated skin-penetrating titanium fixtures used for retaining facial prostheses. Int J Oral Maxillofac Implants (1992) 0.84
Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers. Eur J Neurol (2006) 0.83
Botulinum toxin type A versus anticholinergics for cervical dystonia. Cochrane Database Syst Rev (2005) 0.83
Highlights of the 1990 Leesburg, Virginia, International Workshop on Retrospective Exposure Assessment for Occupational Epidemiology Studies. Scand J Work Environ Health (1991) 0.82
The invariance of the total direct DNA strand break yield. Med Phys (2011) 0.81
Activin type II receptors in embryonic dorsal root ganglion neurons of the chicken. J Neurobiol (2001) 0.81
Dementia and severity of parkinsonism determines the handicap of patients in late-stage Parkinson's disease: the Barcelona-Lisbon cohort. Eur J Neurol (2014) 0.80
Total rhinoplasty or prosthesis? J Prosthet Dent (1980) 0.79
Electrical burns of the oral commissure. J Prosthet Dent (1983) 0.79
The amalgam-composite resin restoration. J Prosthet Dent (1982) 0.79
Color and its application in maxillofacial prosthetics. J Prosthet Dent (1978) 0.79
Pardoprunox as adjunct therapy to levodopa in patients with Parkinson's disease experiencing motor fluctuations: results of a double-blind, randomized, placebo-controlled, trial. Parkinsonism Relat Disord (2012) 0.79
[Health-economic burden of Parkinson's disease in Portugal: a cohort study]. Rev Neurol (2011) 0.78
Essential oil from Zanthoxylum tingoassuiba loaded into multilamellar liposomes useful as antimicrobial agents. J Microencapsul (2009) 0.78
Safety and tolerability of pardoprunox, a new partial dopamine agonist, in a randomized, controlled study of patients with advanced Parkinson's disease. Eur Neurol (2009) 0.77
Dental rehabilitation of the patient with severe caries after radiation therapy. Spec Care Dentist (2013) 0.76
Prophylactic antibiotics and anticonvulsants in neurosurgery. Adv Tech Stand Neurosurg (2011) 0.76
[Influence of placebo effect on planning and analysis of clinical trials]. Rev Port Cardiol (2001) 0.75
Botulinum toxin and dysphagia. Neurology (1992) 0.75
Agreement between clinical examination and quantitative tests of neurologic function among 384 subjects. Am J Ind Med (2001) 0.75
Characterisation of respiratory health and exposures at a sintered permanent magnet manufacturer. Br J Ind Med (1991) 0.75
Building ventilation and symptoms--where do we go from here? Am J Public Health (1994) 0.75
Commentary on "Health economics and the value of therapy in Alzheimer's disease." Value therapy for Alzheimer's disease--a European perspective. Alzheimers Dement (2007) 0.75
Can some upper extremity disorders be defined as work-related? J Hand Surg Am (1996) 0.75
[Cardiac effects of acute poisoning with tricyclic antidepressants: systematic review of the literature -- Part II]. Rev Port Cardiol (2001) 0.75
Letter: Split-renal-function analysis without ureteral catheterization in renovascular hypertension. N Engl J Med (1975) 0.75
Movement Disorders Cochrane Collaborative Review Group. Mov Disord (1997) 0.75
Foreign body-type reaction following crown cementation. J Periodontol (1977) 0.75
Local peri-lesional therapy with rhGM-CSF for Kaposi's sarcoma. Lancet (1993) 0.75
[Cardiac effects of acute poisoning with tricyclic antidepressants: systematic review of the literature -- Part IV]. Rev Port Cardiol (2001) 0.75
Legal and legislative issues. Occup Med (2000) 0.75
Hydrocarbon removal from bilgewater by a combination of air-stripping and photocatalysis. J Hazard Mater (2012) 0.75
Parkinson's disease before age 30. Adv Neurol (1993) 0.75
Dental problems in the wind instrumentalist. Cleve Clin Q (1986) 0.75
Absence or major loss of part of the external ear and its correction. J Prosthet Dent (1974) 0.75
[Etiopathogeny of Parkinson disease. The MPTP revolution]. Acta Med Port (1989) 0.75
Evaluation of adsorbents for volatile methyl siloxanes sampling based on the determination of their breakthrough volume. Talanta (2013) 0.75
Patterns of psychological decompensation in patients with spinal cord syndromes. Dis Nerv Syst (1969) 0.75
Caiman crocodilus yacare plasma kininogen detection. Immunopharmacology (1996) 0.75
[Cardiac effects of acute poisoning with tricyclic antidepressants: systematic review of the literature -- Part III]. Rev Port Cardiol (2001) 0.75
Ex utero intrapartum procedure for delivery of a fetus with a large cervical mass. Eur J Anaesthesiol (2005) 0.75
Anticonvulsants for preventing seizures in patients with chronic subdural haematoma. Cochrane Database Syst Rev (2005) 0.75
The liver is the main organ to clear plasma and tissue kallikreins from rat plasma, in vivo. Adv Exp Med Biol (1986) 0.75
Possible role of Koebner's phenomenon in the development of mucous membrane pemphigoid. J Prosthet Dent (1986) 0.75
The George Harnhart memorial lecture on silicone facial prostheses. NADL J (1976) 0.75
Fabrication of a prosthesis for guiding and fixing radioactive sources in treatment of cancer of the floor of the mouth. J Prosthet Dent (1973) 0.75
Dental care of the radiated patient. J Hosp Dent Pract (1978) 0.75
[Critical assessment of articles on controlled clinical trials II. Results]. Acta Med Port (1999) 0.75
An evaluation of auricular prosthesis using osseointegrated implants. Clin Otolaryngol Allied Sci (1992) 0.75
Predictors of clinical performance of child health associates. J Allied Health (1975) 0.75
Radiation carrier for treatment of nasopharyngeal carcinomas. J Prosthet Dent (1987) 0.75
The private funding of public research. New directions in the administration of occupational and environmental health research. J Occup Med (1994) 0.75
Pilot study of the combination of melphalan, carboplatin and etoposide as a conditioning regimen for relapsed lymphoma patients. Acta Haematol (1999) 0.75
[Cardiac effects of acute poisoning with tricyclic antidepressants: systematic review of the literature. Part I]. Rev Port Cardiol (2001) 0.75
Rapid afterloading with guide fixation of radioactive sources in cancer of the oral cavity. Am J Roentgenol Radium Ther Nucl Med (1974) 0.75